PEG-INF ALFA-2B (ALGERON) VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH

ASL MANBA
Ushbu maqola dastlab Journal of Universal Science Research jurnalida nashr etilgan.

Eshmo’minovich, Raimov Kamol (2025) PEG-INF ALFA-2B (ALGERON) VA TENOFOVIR ALAFENAMID (TAF) KOMBINATSIYASINING SURUNKALI DELTA GEPATITNI DAVOLASHDAGI SAMARADORLIGINI BAHOLASH. Journal of Universal Science Research.

To'liq matn arxivda mavjud emas — maqolaning asl manbasiga havola pastda berilgan.

Annotatsiya

Surunkali delta gepatit (SDG) – gepatit B virusi (HBV) bilan birgalikda yuquvchi kasallik bo‘lib, jigar to‘qimasida og‘ir yallig‘lanish va fibroz jarayonlarini keltirib chiqaradigan kasallikdir. SDG dunyo bo‘yicha gepatitlar orasida eng xavfli va davolashda murakkab bo‘lgan turlaridan biri hisoblanadi.

Hujjat turi: Maqola
Mualliflar:
Muallif
Email
Eshmo’minovich, Raimov Kamol
UNSPECIFIED
Jurnal / Nashr: Journal of Universal Science Research
Nashriyot: "Research Science and Innovation house" LLC
Sana: 20 Noyabr 2025
DOI / ID: oai:ojs.pkp.sfu.ca:article/14578
Eslatma: Imported from Universal Publishings (OAI id oai:ojs.pkp.sfu.ca:article/14578)
URI: https://arxiv.universalpublishings.com/id/eprint/60502
Amallar
[pin missing: title]
[pin missing: title]